Significant Ownership of Paul B. Manning
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Paul B. Manning focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Paul B. Manning - Paul B. Manning
- Manager location
- Charlottesville, VA
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Paul B. Manning with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Paul B. Manning
Significant Ownership of Paul B. Manning
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| VRCA | Verrica Pharmaceuticals Inc. | Common Stock, $0.0001 par value per share | 50% | $28,437,789 | 8,056,031 | Paul B Manning | 25 Nov 2025 | ||
| TSHA | TAYSHA GENE THERAPIES, INC. | Common Stock, $0.00001 par value per share | 9.8% | $59,394,578 | 25,601,111 | Paul B Manning | 30 May 2025 | ||
| CADL | CANDEL THERAPEUTICS, INC. | Common Stock, $0.01 par value per share | 7.9% | $29,997,375 | 5,790,999 | Paul B Manning | 16 Dec 2024 |
Schedules 13D/G Reported by Paul B. Manning:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.